Synthetic route to anti-viral agents
US-9809576-B1 · Nov 7, 2017 · US
Synthetic route to anti-viral agents
US10077256B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10077256-B2 |
| Application number | US-201715804485-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 6, 2017 |
| Priority date | Jul 18, 2014 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
First claim
Opening claim text (preview).
We claim: 1. A compound selected from the group consisting of: salts thereof. 2. The compound of claim 1 , wherein the compound is or a salt thereof. 3. The compound of claim 1 , wherein the compound is or a salt thereof. 4. The compound of claim 1 , wherein the compound is or a salt thereof. 5. The compound of claim 1 , wherein the compound is or a salt thereof. 6. The compound of claim 1 , wherein the compound is or a salt thereof. 7. The compound of claim 1 , wherein the compound is or a salt thereof. 8. The compound of claim 1 , wherein the compound is or a salt thereof. 9. The compound of claim 1 , wherein the compound is or a salt thereof. 10. The compound of claim 1 , wherein the compound is or a salt thereof. 11. The compound of claim 1 , wherein the compound is or a salt thereof. 12. The compound of claim 1 , wherein the compound is or a salt thereof. 13. The compound of claim 1 , wherein the compound is or a salt thereof. 14. The compound of claim 1 , wherein the compound is
Assignees
Inventors
Classifications
by esterification of carboxylic acid groups in the enantiomers or the inverse reaction · CPC title
from amines with formation of carbamate groups · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
by reactions not involving the formation of carbamate groups · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10077256B2 cover?
- The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.
- Who is the assignee on this patent?
- Abbvie Inc
- What technology area does this patent fall under?
- Primary CPC classification C07D403/12. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).